D
Daniel Duerschmied
Researcher at University of Freiburg
Publications - 202
Citations - 6977
Daniel Duerschmied is an academic researcher from University of Freiburg. The author has contributed to research in topics: Extracorporeal membrane oxygenation & Medicine. The author has an hindex of 31, co-authored 173 publications receiving 4737 citations. Previous affiliations of Daniel Duerschmied include Boston Children's Hospital & Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
Extracellular DNA traps promote thrombosis
Tobias A. Fuchs,Alexander Brill,Daniel Duerschmied,Daphne Schatzberg,Marc Monestier,Daniel D. Myers,Shirley K. Wrobleski,Thomas W. Wakefield,John H. Hartwig,Denisa D. Wagner +9 more
TL;DR: It is reported that NETs provide a heretofore unrecognized scaffold and stimulus for thrombus formation and may further explain the epidemiological association of infection with thrombosis.
Journal ArticleDOI
The Effects of Serotonin in Immune Cells
TL;DR: Serotonin can also suppress the release of tumor necrosis factor-α and interleukin-1β by activating serotonin receptors, and neutrophil recruitment and T-cell activation can both be mediated by serotonin.
Journal ArticleDOI
Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice
Daniel Duerschmied,Georgette L. Suidan,Georgette L. Suidan,Melanie Demers,Melanie Demers,Nadine Herr,Carla Carbo,Carla Carbo,Alexander Brill,Alexander Brill,Stephen M. Cifuni,Maximilian Mauler,Sanja Cicko,Michael Bader,Marco Idzko,Christoph Bode,Denisa D. Wagner,Denisa D. Wagner +17 more
TL;DR: Platelet serotonin promotes the recruitment of neutrophils in acute inflammation, supporting an important role for platelet serotonin in innate immunity.
Journal ArticleDOI
Characterization of pre-existing and induced SARS-CoV-2-specific CD8 + T cells.
Isabel Schulien,Janine Kemming,Valerie Oberhardt,Katharina Wild,Lea M. Seidel,Saskia Killmer,Sagar,Franziska Daul,Marilyn Salvat Lago,Annegrit Decker,Hendrik Luxenburger,Benedikt Binder,Dominik Bettinger,Oezlem Sogukpinar,Siegbert Rieg,Marcus Panning,Daniela Huzly,Martin Schwemmle,Georg Kochs,Cornelius F. Waller,Alexandra Nieters,Daniel Duerschmied,Florian Emmerich,Henrik E. Mei,Axel Schulz,Sian Llewellyn-Lacey,David Price,Tobias Boettler,Bertram Bengsch,Robert Thimme,Maike Hofmann,Christoph Neumann-Haefelin +31 more
TL;DR: Cross-reactive and induced SARS-CoV-2-specific CD8 + T cell responses are defined as potentially important determinants of immune protection in mild Sars-Cov-2 infection.
Journal ArticleDOI
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism.
Stavros Konstantinides,Eric Vicaut,Thierry Danays,Cecilia Becattini,Laurent Bertoletti,Jan Beyer-Westendorf,Hélène Bouvaist,Francis Couturaud,Claudia Dellas,Daniel Duerschmied,Klaus Empen,Emile Ferrari,Nazzareno Galiè,David Jiménez,Maciej Kostrubiec,Matija Kozak,Christian Kupatt,Irene M. Lang,Mareike Lankeit,Nicolas Meneveau,Massimiliano Palazzini,Piotr Pruszczyk,Matteo Rugolotto,Aldo Salvi,Olivier Sanchez,Sebastian Schellong,Bożena Sobkowicz,Guy Meyer +27 more
TL;DR: Thrombolytic treatment did not affect long-term mortality rates, and it did not appear to reduce residual dyspnea or RV dysfunction in patients with intermediate-risk PE.